dsdsa

huahana

Maʻemaʻe Kiʻekiʻe 540737-29-9 Tofacitinib citrate no ka JAK Pathway Inhibitor

ʻO ka wehewehe pōkole:


  • Maʻemaʻe:≧99.0%
  • Kūlana Kūlana:Enterprise Standard a i ʻole e like me ka makemake
  • Kaha:35Kgs/Mahina
  • Ke ola papa:ʻEkolu Makahiki
  • Noi:E mālama i ka rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis a me ka ulcerative colitis
  • Pōmaikaʻi Hui:ʻO ka hui kūʻai hoʻokuʻu aku ʻike me ka hoʻomaʻamaʻa ʻoihana ma ka hale hana
  • Huahana Huahana

    FAQ

    Huahana Huahana

    Huahanainoa Tofacitinib Citrate
    Nā huaʻōlelo like (3R,4R)-1-(Cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-3-piperidinamine 2-hydroxy-1,2,3 -propanetricarboxylate;CP 690500-10;CP 690550-10;(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidinepropanenitrile 2-Hydroxy-1,2,3-propanetricarboxylate
    CAS No. 540737-29-9
    Ka nana aku ʻO ke keʻokeʻo i ka pauka keʻokeʻo
    ʻĀpana Molekala C16H20N6OC6H8O7
    Kaumaha Molekala 504.50
    Palapala noi Papa lāʻau lapaʻau a i ʻole kumu noiʻi
    Hoʻopili E like me kāu noi
    Waihona E mālama i loko o nā pahu paʻa a me ka māmā ma kahi anuanu

     

    Tofacitinib Citrate (CAS #540737-29-9)

    NA MEA

    NA KUMU

    HANA

    Ka nana aku

    ʻO ke keʻokeʻo i ka pauka keʻokeʻo

    Pauda keʻokeʻo

    ʻIkepili

    HPLC;IR;HNMR

    Hoʻokō

    Ka hoʻoheheʻe

    Hiki ke hoʻoheheʻe ʻia i DMSO ma 100mg/ml, hiki ʻole ke hoʻoheheʻe ʻia i ka ethanol, hiki ke hoʻoheheʻe ʻia i ka wai etc.

    Hoʻokō

    Nalo ma ka maloo

    ≤0.5%

    0.12%

    Ke koena ma ka ʻā

    ≤0.1%

    0.05%

    Nā metala kaumaha

    ≤10ppm

    Hoʻokō

    Na mea pili

    Diastereomer (RS+SR) ≤0.1%

    Hoʻokahi haumia ≤0.15%

    Huina haumia ≤1.0%

    0.05%

    0.14%

    0.18%

    Enantiomorphism Isomers

    ≤0.2%

    Hoʻokō

    Nā mea hoʻoheheʻe koena

    Ethanol ≤5000ppm

    Methanol ≤3000ppm

    Toluene ≤890ppm

    Hoʻokō

    Maʻiʻo Citrate

    36.2%~40%

    37.8%

    Maemae

    ≥99.0%

    99.38%

    Hoʻāʻo

    60.68%~63.16% o Tofacitinib INN

    98% ~ 102% o Tofacitinib Citrate INN

    62.04%

     

    99.12%

    Manaʻo: Hoʻokō

    ʻIkepili Hui

    √ Ka ʻike piha o ka papa hoʻokele ma ka hale hana a me nā mea ʻenehana akamai;
    √ ʻO ka maikaʻi ka mea i manaʻo nui ʻia, ʻōnaehana QC koʻikoʻi;
    √ 11 makahiki i ʻike i ka lawe ʻana i nā hui kūʻai;
    √ Keʻena hana R&D kūʻokoʻa;
    √ ʻElua mau papa hana GMP lōʻihi i pūlima ʻia;
    √ Nā waiwai waiwai o nā hale hana palaualelo no ka papahana maʻamau;
    √ Kiʻekiʻe Efficiency hui hana me ke ala mau.
    imgsafSDGSHDASFG

  • Mua:
  • Aʻe:

  • E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou